Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 14 | 2026 | 401 | 6.350 |
Why?
|
| Medicaid | 3 | 2025 | 188 | 1.720 |
Why?
|
| Food Hypersensitivity | 2 | 2024 | 8 | 1.640 |
Why?
|
| Social Determinants of Health | 2 | 2025 | 39 | 1.530 |
Why?
|
| Anti-Asthmatic Agents | 3 | 2025 | 88 | 1.240 |
Why?
|
| Emergency Service, Hospital | 4 | 2025 | 402 | 1.190 |
Why?
|
| Child | 12 | 2026 | 2485 | 1.060 |
Why?
|
| Conflict of Interest | 2 | 2017 | 7 | 1.040 |
Why?
|
| Food Supply | 2 | 2024 | 43 | 1.000 |
Why?
|
| Hypersensitivity | 4 | 2023 | 22 | 0.980 |
Why?
|
| Humans | 25 | 2026 | 17622 | 0.930 |
Why?
|
| Trust | 1 | 2025 | 33 | 0.910 |
Why?
|
| Allergy and Immunology | 1 | 2024 | 5 | 0.870 |
Why?
|
| Arkansas | 4 | 2025 | 6 | 0.860 |
Why?
|
| Rhinitis, Allergic | 1 | 2023 | 7 | 0.810 |
Why?
|
| Precision Medicine | 1 | 2024 | 31 | 0.810 |
Why?
|
| Dermatitis, Atopic | 1 | 2023 | 18 | 0.800 |
Why?
|
| Vaccines | 1 | 2025 | 225 | 0.740 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 2020 | 1 | 0.650 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2020 | 6 | 0.650 |
Why?
|
| Vaccination | 1 | 2025 | 726 | 0.620 |
Why?
|
| United States | 6 | 2026 | 3922 | 0.570 |
Why?
|
| Drug Hypersensitivity | 1 | 2018 | 8 | 0.560 |
Why?
|
| Penicillins | 1 | 2018 | 5 | 0.560 |
Why?
|
| Financial Support | 1 | 2017 | 6 | 0.520 |
Why?
|
| Hypercholesterolemia | 1 | 2017 | 25 | 0.510 |
Why?
|
| Biomedical Research | 1 | 2017 | 77 | 0.500 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 208 | 0.490 |
Why?
|
| Hepatitis C | 1 | 2017 | 47 | 0.490 |
Why?
|
| Practice Guidelines as Topic | 2 | 2026 | 319 | 0.490 |
Why?
|
| Hospitalization | 3 | 2025 | 831 | 0.440 |
Why?
|
| Adolescent | 5 | 2025 | 3625 | 0.420 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2014 | 41 | 0.400 |
Why?
|
| Child, Preschool | 3 | 2025 | 1455 | 0.370 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2024 | 29 | 0.360 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2026 | 308 | 0.290 |
Why?
|
| Socioeconomic Factors | 3 | 2023 | 603 | 0.240 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2025 | 9 | 0.230 |
Why?
|
| Spirometry | 1 | 2025 | 59 | 0.230 |
Why?
|
| Cluster Analysis | 1 | 2025 | 90 | 0.220 |
Why?
|
| Male | 4 | 2025 | 10014 | 0.210 |
Why?
|
| Female | 5 | 2026 | 12715 | 0.210 |
Why?
|
| Biological Products | 1 | 2024 | 6 | 0.210 |
Why?
|
| Health Services Accessibility | 2 | 2019 | 269 | 0.210 |
Why?
|
| Patient Education as Topic | 1 | 2025 | 193 | 0.200 |
Why?
|
| Phenotype | 1 | 2024 | 154 | 0.200 |
Why?
|
| Vitamin D Deficiency | 1 | 2023 | 24 | 0.200 |
Why?
|
| Hospitals | 1 | 2024 | 71 | 0.200 |
Why?
|
| Biomarkers | 1 | 2024 | 302 | 0.190 |
Why?
|
| Poverty | 1 | 2024 | 171 | 0.190 |
Why?
|
| Air Pollutants | 1 | 2023 | 59 | 0.180 |
Why?
|
| Air Pollution | 1 | 2023 | 47 | 0.180 |
Why?
|
| Pediatric Obesity | 1 | 2023 | 101 | 0.180 |
Why?
|
| Education, Medical | 1 | 2022 | 25 | 0.180 |
Why?
|
| Racism | 1 | 2022 | 22 | 0.180 |
Why?
|
| Health Equity | 1 | 2022 | 27 | 0.170 |
Why?
|
| Tiotropium Bromide | 1 | 2021 | 3 | 0.170 |
Why?
|
| Risk Assessment | 1 | 2025 | 1093 | 0.170 |
Why?
|
| Patients | 1 | 2021 | 30 | 0.170 |
Why?
|
| Infant | 1 | 2024 | 1228 | 0.160 |
Why?
|
| Retrospective Studies | 2 | 2025 | 2502 | 0.160 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2020 | 1 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 1 | 2021 | 237 | 0.160 |
Why?
|
| Ethics, Clinical | 1 | 2019 | 1 | 0.150 |
Why?
|
| Social Justice | 1 | 2019 | 8 | 0.150 |
Why?
|
| Insurance Coverage | 1 | 2019 | 99 | 0.140 |
Why?
|
| Policy Making | 1 | 2017 | 13 | 0.130 |
Why?
|
| Disclosure | 1 | 2017 | 16 | 0.130 |
Why?
|
| Risk Factors | 1 | 2024 | 3291 | 0.130 |
Why?
|
| Disease Management | 1 | 2017 | 110 | 0.120 |
Why?
|
| Parents | 1 | 2019 | 301 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2026 | 446 | 0.100 |
Why?
|
| Young Adult | 1 | 2019 | 2538 | 0.090 |
Why?
|
| Environmental Exposure | 2 | 2023 | 123 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2026 | 1295 | 0.090 |
Why?
|
| Delivery of Health Care | 1 | 2014 | 383 | 0.080 |
Why?
|
| Aged | 1 | 2021 | 6223 | 0.080 |
Why?
|
| Vital Capacity | 1 | 2025 | 33 | 0.060 |
Why?
|
| Self Administration | 1 | 2025 | 8 | 0.060 |
Why?
|
| Reference Values | 1 | 2025 | 86 | 0.060 |
Why?
|
| Forced Expiratory Volume | 1 | 2025 | 66 | 0.060 |
Why?
|
| Administration, Inhalation | 1 | 2025 | 39 | 0.060 |
Why?
|
| Video Recording | 1 | 2025 | 15 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2025 | 107 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2025 | 214 | 0.050 |
Why?
|
| Cholecalciferol | 1 | 2023 | 16 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2023 | 32 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2023 | 85 | 0.050 |
Why?
|
| Vitamins | 1 | 2023 | 59 | 0.050 |
Why?
|
| Vitamin D | 1 | 2023 | 76 | 0.050 |
Why?
|
| Minority Groups | 1 | 2022 | 104 | 0.050 |
Why?
|
| Curriculum | 1 | 2022 | 54 | 0.040 |
Why?
|
| Health Promotion | 1 | 2023 | 293 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2023 | 1251 | 0.040 |
Why?
|
| Feminism | 1 | 2019 | 1 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2019 | 67 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2019 | 151 | 0.030 |
Why?
|
| Adult | 1 | 2023 | 7621 | 0.020 |
Why?
|
Concepts
(98)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->